Swedbank AB Acquires 4,872 Shares of Humana Inc. $HUM

Swedbank AB raised its stake in shares of Humana Inc. (NYSE:HUM) by 4.9% during the third quarter, Holdings Channel reports. The firm owned 105,269 shares of the insurance provider’s stock after buying an additional 4,872 shares during the quarter. Swedbank AB’s holdings in Humana were worth $27,388,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the stock. IFM Investors Pty Ltd increased its position in shares of Humana by 0.4% during the third quarter. IFM Investors Pty Ltd now owns 23,826 shares of the insurance provider’s stock valued at $6,074,000 after buying an additional 97 shares during the period. Farther Finance Advisors LLC lifted its holdings in Humana by 8.3% in the third quarter. Farther Finance Advisors LLC now owns 1,955 shares of the insurance provider’s stock worth $509,000 after buying an additional 149 shares during the period. OFI Invest Asset Management boosted its position in Humana by 37.4% during the 3rd quarter. OFI Invest Asset Management now owns 536 shares of the insurance provider’s stock valued at $139,000 after acquiring an additional 146 shares in the last quarter. Red Door Wealth Management LLC purchased a new position in shares of Humana during the 3rd quarter worth approximately $201,000. Finally, Trust Point Inc. bought a new position in shares of Humana in the 3rd quarter worth approximately $245,000. 92.38% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HUM has been the topic of several recent research reports. Morgan Stanley reaffirmed an “underperform” rating on shares of Humana in a research note on Thursday, December 18th. Evercore ISI assumed coverage on shares of Humana in a research report on Monday, September 22nd. They issued an “in-line” rating and a $295.00 target price on the stock. The Goldman Sachs Group lowered their price target on shares of Humana from $235.00 to $215.00 and set a “sell” rating for the company in a research report on Monday, November 24th. Robert W. Baird decreased their target price on shares of Humana from $280.00 to $264.00 and set a “neutral” rating for the company in a research note on Thursday, December 11th. Finally, Truist Financial dropped their price target on Humana from $300.00 to $285.00 and set a “hold” rating on the stock in a research report on Monday, November 10th. Nine research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $294.32.

Humana Price Performance

Shares of NYSE HUM opened at $258.78 on Friday. The firm has a market cap of $31.12 billion, a P/E ratio of 24.25, a PEG ratio of 1.52 and a beta of 0.46. Humana Inc. has a twelve month low of $206.87 and a twelve month high of $315.35. The company has a quick ratio of 2.02, a current ratio of 2.02 and a debt-to-equity ratio of 0.68. The company has a 50 day moving average of $258.90 and a 200 day moving average of $259.99.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to the consensus estimate of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.Humana’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period last year, the company earned $4.16 EPS. As a group, research analysts expect that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend is Friday, December 26th. Humana’s payout ratio is 33.18%.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.